General Information of Drug Off-Target (DOT) (ID: OT5I7OI2)

DOT Name Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4)
Synonyms GABA(A) receptor subunit alpha-4
Gene Name GABRA4
Related Disease
Autism ( )
Autism spectrum disorder ( )
Epilepsy ( )
Nicotine dependence ( )
Non-insulin dependent diabetes ( )
Pervasive developmental disorder ( )
Schizophrenia ( )
Sensory ataxia ( )
Status epilepticus seizure ( )
Essential tremor ( )
UniProt ID
GBRA4_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
7QN5; 7QN7; 7QN9; 7QNA; 7QNC
Pfam ID
PF02931 ; PF02932
Sequence
MVSAKKVPAIALSAGVSFALLRFLCLAVCLNESPGQNQKEEKLCTENFTRILDSLLDGYD
NRLRPGFGGPVTEVKTDIYVTSFGPVSDVEMEYTMDVFFRQTWIDKRLKYDGPIEILRLN
NMMVTKVWTPDTFFRNGKKSVSHNMTAPNKLFRIMRNGTILYTMRLTISAECPMRLVDFP
MDGHACPLKFGSYAYPKSEMIYTWTKGPEKSVEVPKESSSLVQYDLIGQTVSSETIKSIT
GEYIVMTVYFHLRRKMGYFMIQTYIPCIMTVILSQVSFWINKESVPARTVFGITTVLTMT
TLSISARHSLPKVSYATAMDWFIAVCFAFVFSALIEFAAVNYFTNIQMEKAKRKTSKPPQ
EVPAAPVQREKHPEAPLQNTNANLNMRKRTNALVHSESDVGNRTEVGNHSSKSSTVVQES
SKGTPRSYLASSPNPFSRANAAETISAARALPSASPTSIRTGYMPRKASVGSASTRHVFG
SRLQRIKTTVNTIGATGKLSATPPPSAPPPSGSGTSKIDKYARILFPVTFGAFNMVYWVV
YLSKDTMEKSESLM
Function GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.
KEGG Pathway
Neuroactive ligand-receptor interaction (hsa04080 )
Retrograde endocan.binoid sig.ling (hsa04723 )
GABAergic sy.pse (hsa04727 )
Taste transduction (hsa04742 )
Morphine addiction (hsa05032 )
Nicotine addiction (hsa05033 )
Reactome Pathway
GABA receptor activation (R-HSA-977443 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Autism DISV4V1Z Strong Biomarker [1]
Autism spectrum disorder DISXK8NV Strong Genetic Variation [2]
Epilepsy DISBB28L Strong Biomarker [3]
Nicotine dependence DISZD9W7 Strong Biomarker [4]
Non-insulin dependent diabetes DISK1O5Z Strong Genetic Variation [5]
Pervasive developmental disorder DIS51975 Strong Genetic Variation [2]
Schizophrenia DISSRV2N Strong Biomarker [6]
Sensory ataxia DISSMCYQ Strong Biomarker [3]
Status epilepticus seizure DISY3BIC Strong Altered Expression [7]
Essential tremor DIS7GBKQ Disputed Genetic Variation [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4). [9]
Estradiol DMUNTE3 Approved Estradiol affects the expression of Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4). [10]
Niclosamide DMJAGXQ Approved Niclosamide increases the expression of Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4). [11]
Isotretinoin DM4QTBN Approved Isotretinoin decreases the expression of Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4). [12]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4). [13]
------------------------------------------------------------------------------------

References

1 Association between GABA(A) receptor subunit polymorphisms and autism spectrum disorder (ASD).Psychiatry Res. 2015 Sep 30;229(1-2):580-2. doi: 10.1016/j.psychres.2015.07.077. Epub 2015 Jul 28.
2 Identification of rare noncoding sequence variants in gamma-aminobutyric acid A receptor, alpha 4 subunit in autism spectrum disorder.Neurogenetics. 2018 Jan;19(1):17-26. doi: 10.1007/s10048-017-0529-1. Epub 2017 Nov 18.
3 Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression.Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11894-9. doi: 10.1073/pnas.0501434102. Epub 2005 Aug 9.
4 Further evidence for an association between the gamma-aminobutyric acid receptor A, subunit 4 genes on chromosome 4 and Fagerstrm Test for Nicotine Dependence.Addiction. 2009 Mar;104(3):471-7. doi: 10.1111/j.1360-0443.2008.02445.x.
5 A genome-wide search for type 2 diabetes susceptibility genes in an extended Arab family.Ann Hum Genet. 2013 Nov;77(6):488-503. doi: 10.1111/ahg.12036. Epub 2013 Aug 13.
6 Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder.Am J Med Genet B Neuropsychiatr Genet. 2010 Oct 5;153B(7):1347-9. doi: 10.1002/ajmg.b.31108.
7 Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy.J Neurosci. 2006 Nov 1;26(44):11342-6. doi: 10.1523/JNEUROSCI.3329-06.2006.
8 Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor.Pharmacogenet Genomics. 2011 Jul;21(7):436-9. doi: 10.1097/FPC.0b013e328345bec0.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Gonadal steroids regulate GABAA receptor subunit mRNA expression in NT2-N neurons. Brain Res Mol Brain Res. 2005 Aug 18;138(2):105-15. doi: 10.1016/j.molbrainres.2004.10.047.
11 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
12 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
13 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.